Ses SA SES SA FDR/ LU0088087324 /
24.05.2024 18:35:16 | Изменение - | Объем сделки | Бид17:40:10 | Предложение17:40:10 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
5.064EUR | - | 12,067 Оборот: 55,204.656 |
-Величина цены спроса: - | -Величина цены предложения: - | 1.95 млрдEUR | 9.52% | - |
GlobeNewswire
02.06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02.06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02.06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02.06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02.06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02.06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02.06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
02.06
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
02.06
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница